Operating
Change in Other Liabilities
Merck & Co. Change in Other Liabilities remained flat by 0.0% to $48.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 498.0%, from -$12.25M to $48.75M. Over 4 years (FY 2021 to FY 2025), Change in Other Liabilities shows a downward trend with a -20.3% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
A decrease indicates the company is paying down its miscellaneous obligations, which is a use of cash.
Detailed definition
This reflects the net change in various short-term and long-term obligations, such as deferred revenue, accrued expenses...
Peer comparison
For companies with large subscription or service businesses, changes in deferred revenue (a component here) are a key indicator of future growth.
Metric ID:
cf_change_in_other_liabilitiesHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $484.00M | -$545.00M | $456.00M | -$49.00M | $195.00M |
| YoY Change | — | -212.6% | +183.7% | -110.7% | +498.0% |
Range-$545.00M – $484.00M
CAGR-20.3%
Avg YoY Growth+89.6%
Median YoY Growth+36.5%
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s change in other liabilities?
- Merck & Co. (MRK) reported change in other liabilities of $48.75M in Q4 2025.
- How has Merck & Co.'s change in other liabilities changed year-over-year?
- Merck & Co.'s change in other liabilities increased by 498.0% year-over-year, from -$12.25M to $48.75M.
- What is the long-term trend for Merck & Co.'s change in other liabilities?
- Over 4 years (2021 to 2025), Merck & Co.'s change in other liabilities has grown at a -20.3% compound annual growth rate (CAGR), from $484.00M to $195.00M.
- What does change in other liabilities mean?
- The change in miscellaneous debts and obligations the company owes to others.